9MBO | pdb_00009mbo

Focused refinement of RPN1 and the C-terminal helix of midnolin in the substrate-engaged human 26S proteasome


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.83 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 9MBO

This is version 1.2 of the entry. See complete history

Literature

Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover.

Zhu, C.Qin, L.Dai, Z.Zuo, P.Yang, A.Zhong, L.Lin, Z.Liang, L.

(2026) Nat Commun 17

  • DOI: https://doi.org/10.1038/s41467-026-71002-0
  • Primary Citation Related Structures: 
    22MM, 9MBO, 9MBP, 9MBQ, 9U3L, 9U4M, 9U7R, 9W39, 9WBG

  • PubMed Abstract: 

    The 26S proteasome typically degrades proteins marked by ubiquitin chains. However, a distinct, ubiquitin-independent degradation pathway for nuclear proteins exists, mediated by the adaptor protein midnolin, yet its molecular mechanism remains poorly understood. Here, we present nine cryo-electron microscopy structures of the human 26S proteasome in complex with midnolin, which collectively delineate a near-complete catalytic cycle. Our structures reveal that midnolin binds to the proteasome via the RPN1 subunit by its C-terminal helix. Unexpectedly, its ubiquitin-like domain interacts with the RPN11 deubiquitinase in a non-catalytic role. This interaction positions the adjacent Catch domain, which is responsible for substrate binding, directly above the proteasomal entrance, potentially facilitating substrate entry into the proteasome. Furthermore, we observe four consecutive spiral staircase conformations of the AAA+ ATPase hexamer during substrate translocation. These findings provide insights into the mechanisms underlying ubiquitin-independent nuclear protein degradation and may help develop strategies for targeting nuclear proteins via direct proteasomal degradation.


  • Organizational Affiliation
    • Department of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Macromolecule Content 

  • Total Structure Weight: 149.59 kDa 
  • Atom Count: 6,770 
  • Modeled Residue Count: 871 
  • Deposited Residue Count: 1,376 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Midnolin468Homo sapiensMutation(s): 0 
Gene Names: MIDN
UniProt & NIH Common Fund Data Resources
Find proteins for Q504T8 (Homo sapiens)
Explore Q504T8 
Go to UniProtKB:  Q504T8
PHAROS:  Q504T8
GTEx:  ENSG00000167470 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ504T8
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
26S proteasome non-ATPase regulatory subunit 2908Homo sapiensMutation(s): 0 
Gene Names: PSMD2TRAP2
UniProt & NIH Common Fund Data Resources
Find proteins for Q13200 (Homo sapiens)
Explore Q13200 
Go to UniProtKB:  Q13200
PHAROS:  Q13200
GTEx:  ENSG00000175166 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13200
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.83 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China32171224

Revision History  (Full details and data files)

  • Version 1.0: 2026-03-25
    Type: Initial release
  • Version 1.1: 2026-04-01
    Changes: Data collection, Database references
  • Version 1.2: 2026-04-08
    Changes: Data collection, Database references